These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 33000268)
1. MicroRNA‑422a functions as a tumor suppressor in glioma by regulating the Wnt/β‑catenin signaling pathway via RPN2. Sun J; Chen Z; Xiong J; Wang Q; Tang F; Zhang X; Mo L; Wang C; Fan W; Wang J Oncol Rep; 2020 Nov; 44(5):2108-2120. PubMed ID: 33000268 [TBL] [Abstract][Full Text] [Related]
2. circTOP2A functions as a ceRNA to promote glioma progression by upregulating RPN2. Sun J; Wang J; Li M; Li S; Li H; Lu Y; Li F; Xin T; Jin F Cancer Sci; 2023 Feb; 114(2):490-503. PubMed ID: 36227125 [TBL] [Abstract][Full Text] [Related]
3. RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway. Sun J; Ma Q; Li B; Wang C; Mo L; Zhang X; Tang F; Wang Q; Yan X; Yao X; Wu Q; Shu C; Xiong J; Fan W; Wang J Cell Death Dis; 2020 Oct; 11(10):890. PubMed ID: 33087705 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑301a/ZNRF3/wnt/β‑catenin signal regulatory crosstalk mediates glioma progression. Sun J; Ma Q; Shu C; Xiong J; Li B; Wu J; Zhang S; Li J; Liu J; Wang J Int J Oncol; 2021 Jan; 58(1):45-56. PubMed ID: 33367931 [TBL] [Abstract][Full Text] [Related]
5. CircNFIX promotes progression of glioma through regulating miR-378e/RPN2 axis. Ding C; Wu Z; You H; Ge H; Zheng S; Lin Y; Wu X; Lin Z; Kang D J Exp Clin Cancer Res; 2019 Dec; 38(1):506. PubMed ID: 31888753 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of RPN2 induces apoptosis and inhibits migration and invasion in colon carcinoma. Bi C; Jiang B Oncol Rep; 2018 Jul; 40(1):283-293. PubMed ID: 29749494 [TBL] [Abstract][Full Text] [Related]
7. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway. Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987 [TBL] [Abstract][Full Text] [Related]
8. Ribophorin II promotes cell proliferation, migration, and invasion in esophageal cancer cells Li Y; Huang C; Bai Q; Yu J Biosci Rep; 2019 May; 39(5):. PubMed ID: 30940778 [TBL] [Abstract][Full Text] [Related]
9. lncRNA KTN1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑505‑3p. Mu Y; Tang Q; Feng H; Zhu L; Wang Y Oncol Rep; 2020 Dec; 44(6):2645-2655. PubMed ID: 33125151 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of RPN2 suppresses radiosensitivity of glioma cells by activating STAT3 signal transduction. Li C; Ran H; Song S; Liu W; Zou W; Jiang B; Zhao H; Shao B Mol Med; 2020 May; 26(1):43. PubMed ID: 32404045 [TBL] [Abstract][Full Text] [Related]
11. miR‑296‑3p promotes the proliferation of glioblastoma cells by targeting ICAT. Zhou J; Du G; Fu H Mol Med Rep; 2020 May; 21(5):2151-2161. PubMed ID: 32323769 [TBL] [Abstract][Full Text] [Related]
12. Long non‑coding RNA Unigene56159 promotes glioblastoma multiforme cell proliferation and invasion through negatively regulating microRNA‑194‑5p. Jiang G; Dong H; Dong Y; Yang X Mol Med Rep; 2020 Feb; 21(2):768-776. PubMed ID: 31789416 [TBL] [Abstract][Full Text] [Related]
13. SMARCC2 combined with c‑Myc inhibits the migration and invasion of glioma cells via modulation of the Wnt/β‑catenin signaling pathway. Li C; Fei C; Li J; Wu H; Chen L; Roshani R; Li H; Shi L; Song C; Gu J; Lu Y; Zhou Q Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080022 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway. Sun WM; Tao W; Li JC; Zhu DM; Miao Y Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196 [TBL] [Abstract][Full Text] [Related]
15. Verbascoside inhibits progression of glioblastoma cells by promoting Let-7g-5p and down-regulating HMGA2 via Wnt/beta-catenin signalling blockade. Jia WQ; Zhu JW; Yang CY; Ma J; Pu TY; Han GQ; Zou MM; Xu RX J Cell Mol Med; 2020 Mar; 24(5):2901-2916. PubMed ID: 32000296 [TBL] [Abstract][Full Text] [Related]
16. Prognostic and therapeutic impact of RPN2-mediated tumor malignancy in non-small-cell lung cancer. Fujita Y; Yagishita S; Takeshita F; Yamamoto Y; Kuwano K; Ochiya T Oncotarget; 2015 Feb; 6(5):3335-45. PubMed ID: 25595901 [TBL] [Abstract][Full Text] [Related]
17. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker. Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653 [TBL] [Abstract][Full Text] [Related]
18. Long non‑coding RNA FLVCR1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑30b‑3p. Gao W; Li H; Liu Y; Zhang Y; Zhao H; Liu F Mol Med Rep; 2020 Aug; 22(2):723-732. PubMed ID: 32626942 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1. Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561 [TBL] [Abstract][Full Text] [Related]
20. MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma. Liu PJ; Ye YX; Wang YX; Du JX; Pan YH; Fang XB Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6612-6620. PubMed ID: 31378903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]